186 related articles for article (PubMed ID: 20605819)
21. [A case of PAN with positive Hbs Ag cured by immunosuppressive and antiviral therapies: a case report].
Choucair J; Hajj G; Abi Karam G
J Med Liban; 2007; 55(1):50-2. PubMed ID: 17489308
[TBL] [Abstract][Full Text] [Related]
22. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
Chen FW; Coyle L; Jones BE; Pattullo V
Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus induced cytoplasmic antineutrophil cytoplasmic antibody-mediated vasculitis causing subarachnoid hemorrhage, acute transverse myelitis, and nephropathy: a case report.
Joshi U; Subedi R; Gajurel BP
J Med Case Rep; 2017 Apr; 11(1):91. PubMed ID: 28366165
[TBL] [Abstract][Full Text] [Related]
24. Polyarteritis nodosa.
Forbess L; Bannykh S
Rheum Dis Clin North Am; 2015; 41(1):33-46, vii. PubMed ID: 25399938
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
Xiong QF; Zhong YD; Hu ZL; Yang YF
Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219
[TBL] [Abstract][Full Text] [Related]
26. HBV-associated cryoglobulinemic vasculitis: remission after antiviral therapy with entecavir.
Viganò M; Martin P; Cappelletti M; Fabrizi F
Kidney Blood Press Res; 2014; 39(1):65-73. PubMed ID: 25011658
[TBL] [Abstract][Full Text] [Related]
27. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.
Guillevin L; Lhote F; Leon A; Fauvelle F; Vivitski L; Trepo C
J Rheumatol; 1993 Feb; 20(2):289-98. PubMed ID: 8097249
[TBL] [Abstract][Full Text] [Related]
28. [Extravascular and perivascular granulomas and necrotizing vasculitis associated with hepatitis B antigen in the blood].
Stamenkovic I; Schifferli JA
Ann Med Interne (Paris); 1986; 137(8):663-5. PubMed ID: 2882714
[TBL] [Abstract][Full Text] [Related]
29. [The changing face of medium-sized vasculitis].
Parada-Turska J; Turska M
Wiad Lek; 2018; 71(1 pt 1):64-72. PubMed ID: 29558354
[TBL] [Abstract][Full Text] [Related]
30. Vasculitis with hepatitis B antigenemia: long-term observation in nine patients.
Sergent JS; Lockshin MD; Christian CL; Gocke DJ
Medicine (Baltimore); 1976 Jan; 55(1):1-18. PubMed ID: 1628
[TBL] [Abstract][Full Text] [Related]
31. The role of entecavir in preventing hepatitis B recurrence after liver transplantation.
Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Wang X; Shen CH; Luo Y; Xin TY; Wang SY; Qiu DK
J Dig Dis; 2009 Nov; 10(4):321-7. PubMed ID: 19906113
[TBL] [Abstract][Full Text] [Related]
32. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
33. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
[TBL] [Abstract][Full Text] [Related]
34. Classic polyarteritis nodosa presenting rare clinical manifestations in a patient with hemophilia A.
Matsushita T; Adachi H; Watanabe H; Shimoyama Y; Adachi T; Sobue G; Ito M; Kojima T; Saito H; Naoe T
Int J Hematol; 2006 Jun; 83(5):420-5. PubMed ID: 16787873
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
Suzuki Y; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Miyakawa Y; Kumada H
J Gastroenterol Hepatol; 2009 Mar; 24(3):429-35. PubMed ID: 19226381
[TBL] [Abstract][Full Text] [Related]
36. Hypertensive crisis, hepatitis B virus and polyarteritis nodosa in a child.
Belot A; Ranchin B; Canterino I; Trepo C; Dubourg L; Cochat P
Pediatr Nephrol; 2007 Jan; 22(1):97-100. PubMed ID: 17106693
[TBL] [Abstract][Full Text] [Related]
37. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
38. Polyarteritis nodosa: A contemporary overview.
De Virgilio A; Greco A; Magliulo G; Gallo A; Ruoppolo G; Conte M; Martellucci S; de Vincentiis M
Autoimmun Rev; 2016 Jun; 15(6):564-70. PubMed ID: 26884100
[TBL] [Abstract][Full Text] [Related]
39. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
[TBL] [Abstract][Full Text] [Related]
40. Polyarteritis nodosa and HIV infection: no evidence of a direct pathogenic role of HIV.
Massari M; Salvarani C; Portioli I; Ramazzotti E; Gabbi E; Bonazzi L
Infection; 1996; 24(2):159-61. PubMed ID: 8740112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
